BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31025121)

  • 1. Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.
    Montesi SB; Caravan P
    Curr Rheumatol Rep; 2019 Apr; 21(6):25. PubMed ID: 31025121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
    Chung JH; Walker CM; Hobbs S
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests.
    Landini N; Orlandi M; Calistri L; Nardi C; Ciet P; Bellando-Randone S; Guiducci S; Benkert T; Panebianco V; Morana G; Matucci-Cerinic M; Colagrande S
    Eur J Radiol; 2024 Jan; 170():111239. PubMed ID: 38056347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
    Gargani L; Bruni C; De Marchi D; Romei C; Guiducci S; Bellando-Randone S; Aquaro GD; Pepe A; Neri E; Colagrande S; Falaschi F; Moggi-Pignone A; Pingitore A; Matucci-Cerinic M
    Clin Rheumatol; 2021 May; 40(5):1903-1912. PubMed ID: 33161470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis.
    Pinal-Fernandez I; Pineda-Sanchez V; Pallisa-Nuñez E; Simeon-Aznar CP; Selva-O'Callaghan A; Fonollosa-Pla V; Vilardell-Tarres M
    Clin Rheumatol; 2016 Sep; 35(9):2339-45. PubMed ID: 27107755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
    Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
    Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods.
    Ufuk F; Demirci M; Altinisik G
    Eur Radiol; 2020 Aug; 30(8):4369-4380. PubMed ID: 32193641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
    Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
    Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of progression in systemic sclerosis patients with interstitial lung disease.
    Distler O; Assassi S; Cottin V; Cutolo M; Danoff SK; Denton CP; Distler JHW; Hoffmann-Vold AM; Johnson SR; Müller Ladner U; Smith V; Volkmann ER; Maher TM
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32079645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study.
    Mohammad Reza Beigi D; Pellegrino G; Loconte M; Landini N; Mattone M; Paone G; Truglia S; Di Ciommo FR; Bisconti I; Cadar M; Stefanantoni K; Panebianco V; Conti F; Riccieri V
    Rheumatology (Oxford); 2024 May; 63(5):1240-1245. PubMed ID: 37399086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis.
    Molberg Ø; Hoffmann-Vold AM
    Curr Opin Rheumatol; 2016 Nov; 28(6):613-8. PubMed ID: 27387267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.
    Barskova T; Gargani L; Guiducci S; Randone SB; Bruni C; Carnesecchi G; Conforti ML; Porta F; Pignone A; Caramella D; Picano E; Cerinic MM
    Ann Rheum Dis; 2013 Mar; 72(3):390-5. PubMed ID: 22589373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Imaging Strategies in Systemic Sclerosis.
    Wolf M; Montesi SB
    Curr Rheumatol Rep; 2020 Aug; 22(9):57. PubMed ID: 32785794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Four Corners Sign: A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Walkoff L; White DB; Chung JH; Asante D; Cox CW
    J Thorac Imaging; 2018 May; 33(3):197-203. PubMed ID: 29346191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease (SSc-ILD).
    Wangkaew S; Losuriya P; Euathrongchit J
    Clin Rheumatol; 2021 Mar; 40(3):955-963. PubMed ID: 32803568
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ledoult E; Morelle M; Soussan M; Mékinian A; Béhal H; Sobanski V; Hachulla E; Huglo D; Le Gouellec N; Remy-Jardin M; Baillet C; Launay D
    Arthritis Res Ther; 2021 Mar; 23(1):76. PubMed ID: 33673861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis.
    Tardella M; Di Carlo M; Carotti M; Filippucci E; Grassi W; Salaffi F
    Medicine (Baltimore); 2018 May; 97(18):e0566. PubMed ID: 29718851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.
    Richardson C; Agrawal R; Lee J; Almagor O; Nelson R; Varga J; Cuttica MJ; Dematte JD; Chang RW; Hinchcliff ME
    Semin Arthritis Rheum; 2016 Aug; 46(1):109-14. PubMed ID: 27033049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.